Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer Journal Article


Authors: Arbour, K. C.; Riely, G. J.
Article Title: Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer
Keywords: mitogen activated protein kinase; treatment outcome; mutation; bevacizumab; erlotinib; cancer combination chemotherapy; drug efficacy; monotherapy; cancer immunotherapy; progression free survival; epidermal growth factor receptor; editorial; drug resistance; phosphatidylinositol 3 kinase; drug receptor binding; drug response; pazopanib; binding site; maximum tolerated dose; b raf kinase; disease exacerbation; drug delivery system; epidermal growth factor receptor kinase inhibitor; programmed death 1 receptor; non small cell lung cancer; molecularly targeted therapy; afatinib; human; priority journal; osimertinib
Journal Title: Cancer
Volume: 124
Issue: 11
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2018-06-01
Start Page: 2272
End Page: 2275
Language: English
DOI: 10.1002/cncr.31289
PROVIDER: scopus
PUBMED: 29645085
DOI/URL:
Notes: Editorial -- Export Date: 2 July 2018 -- Source: Scopus
Altmetric Score
MSK Authors
  1. Gregory J Riely
    344 Riely
  2. Kathryn Cecilia Arbour
    14 Arbour